The differing positive rate of PDGFRB between non-metastatic osteosarcoma primary lesions and metastatic primary lesions was not statistically significant (54.44% ± 33.86% vs. 29.44% ± 30.87%, p = 0.1212, Fig. 4e). This evidence concerns the gene PDGFRB and osteosarcoma.